Solstice Minerals Limited (ASX:SLS) has applied for the quotation of 167,054 fully paid ordinary shares on the ASX, issued on 6 November 2026 following the conversion of vested performance rights for nil consideration under two separate performance rights classes.

Key Points

  • 167,054 fully paid ordinary shares issued on 6 November 2026 from the conversion of vested performance rights
  • 95,242 shares converted from SLSAJ performance rights expiring 08-Aug-2029; 71,812 shares from SLSAG performance rights expiring 18-Jul-2027
  • All shares issued for nil cash consideration and rank equally with existing ordinary shares from their issue date
  • Total quoted ordinary shares following quotation will be 172,827,440

Performance Rights Conversion Details

According to the filing, the 167,054 new ordinary shares arise from the conversion of two classes of performance rights. The first tranche comprises 95,242 shares converted from SLSAJ performance rights expiring 08 August 2029, with a last conversion date of 6 November 2026. The second tranche comprises 71,812 shares converted from SLSAG performance rights expiring 18 July 2027, also with a last conversion date of 6 November 2026. The filing states both tranches were issued under an employee incentive scheme, with key management personnel or associates holding the converting securities in both cases.

Nil Consideration and Ranking of New Shares

The filing states that fully paid ordinary shares were issued upon the conversion of vested performance rights for nil consideration, with the estimated value of consideration provided per security recorded at $0.000000. The new securities are not being issued for cash consideration. The filing confirms that all 167,054 shares to be quoted will rank equally in all respects from their issue date with the existing issued ordinary shares in the same class. The shares are described as intended to be, but not yet, quoted by ASX at the time of the filing.

Issued Capital Following Quotation

Following the quotation of the 167,054 new shares, the total number of quoted ordinary fully paid shares on issue will be 172,827,440, according to the filing. The company's unquoted securities will include, among others, 1,433,585 SLSAJ performance rights expiring 08 August 2029, 410,565 SLSAG performance rights expiring 18 July 2027, 3,000,000 SLSAE options expiring 24 January 2027 at an exercise price of $0.29, and 1,500,000 SLSAM options expiring 22 June 2029 at an exercise price of $2.10, as set out in the issued capital table in the filing.